- About Us
- Locations
- Meet the Team
- Patient Resources
- Services
Proudly Part of Privia Health
What’s All the Buzz About Heart Failure and SGLT2 Inhibitors?
If you or someone you love has heart problems, you may have heard about a new kind of medicine making waves in the medical world. It’s called an SGLT2 inhibitor. That’s a long name, but don’t worry—we’ll break it down for you.
The exciting part? Doctors now recommend SGLT2 inhibitors even for people who don’t have diabetes. Yes, you read that right!
This blog will explain:
Let’s get started.
What Is Heart Failure?
Heart failure doesn’t mean your heart has stopped working. It means your heart isn’t pumping blood as well as it should.
Think of your heart like a pump. When it’s weak, your body doesn’t get enough blood, oxygen, or nutrients. That can make you tired, short of breath, or swollen in the legs and feet.
There Are Two Main Types of Heart Failure:
Both types can make you feel sick, and both can be helped by new treatments—including SGLT2 inhibitors.
What Are SGLT2 Inhibitors?
SGLT2 stands for “sodium-glucose co-transporter 2.” That’s a fancy way of saying this medicine helps your body get rid of sugar in your pee. It was first used to help people with type 2 diabetes lower their blood sugar.
Examples of SGLT2 Inhibitors:
You may have seen commercials about these medicines for diabetes. But now doctors are prescribing them for people with heart failure—even if they don’t have diabetes.
So How Does a Diabetes Drug Help the Heart?
It may seem strange, but scientists discovered that SGLT2 inhibitors do much more than just help with blood sugar.
Here’s how they help the heart:
It’s like a bonus package—one medicine, many benefits.
The Big News: First-Line Treatment for Some Heart Failure Patients
In the past, SGLT2 inhibitors were only used after trying other heart medicines first. But now, new studies show they’re so helpful that doctors are moving them up the list.
What Does First-Line Mean?
First-line means it’s one of the first medicines your doctor may choose for you. It’s no longer just
an “add-on.” It’s a key player.
This change mostly affects people with:
This is a big deal. It shows how much doctors trust the benefits of this medication.
What Do the Studies Say?
There have been many big studies over the past few years. Let’s look at two important ones:
1. DAPA-HF Trial
2. EMPEROR-Preserved Trial
Doctors were amazed. Now, major heart groups like the American College of Cardiology (ACC) and the American Heart Association (AHA) recommend these drugs early in treatment.
Who Should Consider Taking an SGLT2 Inhibitor?
You may be a good fit if:
Of course, every person is different. Your doctor will look at your medical history, bloodwork, and other medicines before making a decision.
Are There Any Risks or Side Effects?
Like all medicines, SGLT2 inhibitors can have side effects. Most are mild, but some need medical attention.
Common Side Effects:
Rare But Serious Risks:
Let your doctor know if you feel faint, very tired, or notice any signs of infection.
What Should You Ask Your Doctor?
Here are some questions you might want to ask:
Don’t be afraid to ask questions! It’s your body, and you deserve to understand your treatment.
Do You Still Need Other Heart Medications?
Yes. SGLT2 inhibitors are powerful, but they’re part of a team of medicines. Most people with heart failure still take:
Together, they help your heart work better and help you feel better.
Why Is This News So Exciting?
This is one of the few times a drug meant for one thing (diabetes) has turned out to help in totally new ways. It shows how science keeps moving forward—and how treatments can get better over time.
For patients, this means:
That’s why doctors are so excited. And it’s why you should be, too.
Bottom Line: What You Need to Know
Simple Summary (Quick Takeaway):
SGLT2 inhibitors like Farxiga and Jardiance aren’t just for diabetes anymore. If you have heart failure—even without diabetes—these medicines might help you live better and longer. Ask your doctor if they’re right for you